American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2022

The American Academy of Child and Adolescent Psychiatry (AACAP) Pediatric Psychopharmacology Update Institute 2022 focused on advances in child and adolescent psychopharmacology, including impulsive aggression management, medication selection, and comparative efficacy. The event featured expert-led presentations, small-group case discussions, and Q&A panels

The American Academy of Child and Adolescent Psychiatry’s (AACAP) 2022 Pediatric Psychopharmacology Update Institute is an educational event focusing on the latest research and clinical practice in pediatric psychopharmacology. It’s designed for child and adolescent psychiatrists, offering a comprehensive overview of evidence-based pharmacological approaches for treating mental disorders in youth. 

Here’s what the institute typically includes:

Expert-Led Presentations:

Ten top child and adolescent psychiatric research clinicians deliver presentations on current research and clinical recommendations. 

Focus on Emerging Treatments:

The institute often covers clinical trial networks and measurement-based care, providing insights into how new treatments are developed and implemented in practice. 

Comparative Analysis:

It may compare and contrast norms, epidemiology, and clinical practice in the US and Canada. 

Why Attend?

Stay Up-to-Date:
The institute keeps professionals informed about the latest advancements in pediatric psychopharmacology.

The American Academy of Child and Adolescent Psychiatry (AACAP) Pediatric Psychopharmacology Update Institute 2022 was designed for child and adolescent psychiatrists, pediatricians, nurse practitioners, and other mental health professionals. The event focused on impulsive aggression management, medication selection, and comparative efficacy in pediatric psychopharmacology
 
+ Topics:
Advanced Pharmacotherapy for Pediatric Depression.mp3
Advanced Pharmacotherapy for Pediatric Depression.mp4
Children With Outbursts_ Who Are They, What Happens to Them, and What Can We Do About Them_.mp3
Children With Outbursts_ Who Are They, What Happens to Them, and What Can We Do About Them_.mp4
Clinical Pearls for the Pharmacological Management of Pediatric Bipolar Disorder.mp3
Clinical Pearls for the Pharmacological Management of Pediatric Bipolar Disorder.mp4
Key Components of Substance Use Disorder Treatment for the Child Psychiatrist.mp3
Key Components of Substance Use Disorder Treatment for the Child Psychiatrist.mp4
New Psychotropic Agents.mp3
New Psychotropic Agents.mp4
Pharmacotherapies for Early Onset Psychosis and Psychotic Symptoms.mp3
Pharmacotherapies for Early Onset Psychosis and Psychotic Symptoms.mp4
Pharmacotherapy in Autism Spectrum Disorder and Intellectual Disability (Intellectual Developmental Disorder).mp3
Pharmacotherapy in Autism Spectrum Disorder and Intellectual Disability (Intellectual Developmental Disorder).mp4
Practical Approaches to ADHD Pharmacotherapy_ What’s Easy, What’s New, What’s Complicated.mp3
Practical Approaches to ADHD Pharmacotherapy_ What’s Easy, What’s New, What’s Complicated.mp4
Q&A Discussion 1.mp3
Q&A Discussion 1.mp4
Q&A Discussion 2.mp3
Q&A Discussion 2.mp4
Tics, Twitches, and More_ Update on Tools for our Medication Toolkits.mp3
Tics, Twitches, and More_ Update on Tools for our Medication Toolkits.mp4
Update on the Treatment of Pediatric Anxiety Disorders.mp3
Update on the Treatment of Pediatric Anxiety Disorders.mp4